| Myocardial Infarction (MI) |
1 |
1 |
| Cardiovascular Risk Management |
0 |
0.75 |
| Heart Failure (HF) |
0 |
0.64 |
| Rheumatoid Arthritis |
0 |
0.64 |
| Arthritis |
0 |
0.61 |
| Hypertension |
0 |
0.55 |
| Heart |
0 |
0.46 |
| Cardiovascular Imaging |
0 |
0.34 |
| Systemic Lupus Erythematosus |
0 |
0.28 |
| Cardiovascular disease |
0 |
0.23 |
| Lupus |
0 |
0.23 |
| Preventive Screening |
0 |
0.23 |
| Autoimmune Disease |
0 |
0.99 |
| Clinical Guidelines |
0 |
0.15 |
| Inflammatory Bowel Disease |
0 |
0.15 |
| Medicare |
0 |
0.15 |
| Pain Management |
0 |
0.15 |
| Psoriasis |
0 |
0.15 |
| Rheumatic Disease |
0 |
0.15 |
| Scleroderma |
0 |
0.15 |
| Blood Vessel |
0 |
0.11 |
| Pulmonary Arterial Hypertension |
0 |
0.11 |
| Renal Disease |
0 |
0.11 |
| Ulcerative Colitis |
0 |
0.11 |
| Anatomy |
0 |
0.08 |
| Anemia |
0 |
0.08 |
| Angiography |
0 |
0.08 |
| Anticoagulation Therapy |
0 |
0.08 |
| Artery |
0 |
0.08 |
| Blood |
0 |
0.08 |
| Colitis |
0 |
0.08 |
| Exercise |
0 |
0.08 |
| Fatigue |
0 |
0.08 |
| Frailty |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Infarction |
0 |
0.08 |
| Kidney |
0 |
0.08 |
| New York |
0 |
0.08 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.08 |
| Pain |
0 |
0.08 |
| Percutaneous Coronary Intervention |
0 |
0.08 |
| Prognosis |
0 |
0.08 |
| Pulmonary Hypertension |
0 |
0.08 |
| Stent |
0 |
0.08 |
| Steroids |
0 |
0.08 |
| Systemic Sclerosis |
0 |
0.08 |
| Targeted Cancer Therapy |
0 |
0.08 |
| Traction |
0 |
0.08 |
| Biologic Therapy |
0 |
0.07 |
| Hypothyroidism |
0 |
0.07 |
| Thyroid Disease |
0 |
0.07 |